APEIRON Biologics AG at a glance: APEIRON Biologics is a privately held European biotech company based in Vienna, Austria, focused on the discovery and development of treatments for respiratory diseases and novel cancer immunotherapies. APEIRON Biologics´ projects and technologies are based on a strong patent portfolio and partnerships with leading pharmaceutical companies and academic institutions.
APEPTICO Forschung und Entwicklung GmbH is a privately-held development stage biotechnology company in Vienna, Austria, developing peptide-based products targeting life-threatening pulmonary diseases.
Aposcience AG is unique in having developed a secretome-based regenerative therapy. The secretome is produced under GMP-conditions and was approved by the Austrian regulatory agency for a clinical phase II trial. Our product platform Aposec consists of two products: APO-1 - Aposec for internal diseases (acute myocardial infarction, spinal cord injury and stroke) APO-2 - Aposec for topical application (hard-healing wounds, diabetic ulcers)
ARAX Capital Partners is one of the leading venture capitalists in Austria. We have been financing emerging Austrian high-tech and biotech companies in the high-tech and biotech sectors since 2007. One of our driving success factors are the complementary skills of our multidisciplinary team. We are convinced that besides quality, the diversity of experience backgrounds is essential. Our experienced management team has industry expertise and is characterized by first-class industry know-how.
The ASKIN
AstraZeneca Österreich GmbH is one of the leading pharmaceutical companies in Austria and develops, manufactures and markets innovative drugs for the treatment of diseases in the fields of cardiovascular and metabolism, oncology, respiratory diseases and for the treatment of infectious and autoimmune diseases.
AURIMOD is a commercial stage medical device company from Vienna, Austria, offering user centric solutions for pain patients. Our product VIVO offers unique minimally invasive and personalized chronic pain treatment. VIVO is a wearable neuromodulation device to be worn behind the ear utilizing auricular vagus nerve stimulation (aVNS). VIVO allows non-pharmacological treatment of chronic low back pain and migraine with a clinically proven and sustainable therapeutic effect.
Austria Wirtschaftsservice GmbH (aws) is the promotional bank of the Austrian federal government. It supports companies in implementing their innovative projects by offering soft loans, grants and guarantees, particularly in cases where the funds required cannot be obtained sufficiently through alternative funding. LISA - Life Science Austria run by Austria Wirtschaftsservice aims at positioning Austria as a leading life science location offering a variety of support measures.